ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clock gene NR1D1 might be a novel target for the treatment of bladder cancer

Yang, Yubo; Bai, Yunjin; Wang, Xiaoming; Guo, Yaochuan; Yu, Zhihai; Feng, Dechao; Zhang, Facai; Li, Dengxiong; Han, Ping*四川大学; 重庆大学
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS2023-7DOI: 10.1016/j.urolonc.2023.04.021
1被引9阅读
引用收藏
分享

摘要

Purpose: To explore the role of circadian clock gene NR1D1 (REV-erb alpha) in bladder cancer (BC). @@@ Methods: Firstly, the association of NR1D1 level with clinical characteristics and prognosis was investigated among patients diagnosed with BC. Secondly, CCK-8, transwell, and colony formation experiments were performed among BC cells treated with Rev-erb alpha agonist (SR9009), as well as lentivirus and siRNA, for which NR1D1 were overexpressed (OE) and knocked down (KD), respectively. Thirdly, cell cycle and apoptosis were tested by flowcytometry. PI3K/AKT/mTOR pathway proteins were determined in OE-NR1D1 cells. Finally, OE-NR1D1 and OE-Control BC cells were subcutaneously implanted in BALB/c nude mice. The tumor size and protein levels were compared between groups. A P < 0.05 was considered as statistically significant. @@@ Results: Patients with NR1D1 positive status had a longer disease-free survival than those with negative expression. The cell viability, migration, and colony formation of BC cells after treated with SR9009 were significantly suppressed. OE-NR1D1 cells had obviously inhib-ited cell viability, migration, and colony formation, while those were found strengthened in KD-NR1D1 cells. Besides, KD-NR1D1 cells were observed with a lower proportion of dead cells and G0/G1 cells, but a higher ratio of G2/M. The changes of p-AKT, p-S6, p-4EBP1, and FASN involved in PI3K/AKT/mTOR pathway were detected in OE-and KD-NR1D1 BC cells. Finally, in vivo data demonstrated that overexpression of NR1D1 suppressed the tumorigenicity of BC cells. @@@ Conclusion: NR1D1 played a role of tumor suppressor and it might become a novel target for the treatment of BC.

学科与关键词

关键词
Circadian clock geneBladder cancerRev-erbamTOR
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
发表日期
2023-07
卷期
第 41 卷, 第 7 期
DOI
10.1016/j.urolonc.2023.04.021
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82203298]; Sichuan Science and Technology Program [2022YFS0306]; Program for Talents of Chongqing University Three Gorges Hospital [ZX-50010101-2022-347]

作者

  • Y

    Yang, Yubo (第一作者)

    sichuan univ · chongqing univ

  • B

    Bai, Yunjin

    sichuan univ

查看全部 9 位作者收起作者
  • W

    Wang, Xiaoming

    sichuan univ

  • G

    Guo, Yaochuan

    chongqing univ

  • Y

    Yu, Zhihai

    chongqing univ

  • F

    Feng, Dechao

    sichuan univ

  • Z

    Zhang, Facai

    sichuan univ

  • L

    Li, Dengxiong

    sichuan univ

  • H

    Han, Ping (通讯)

    sichuan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417